Dr Henry Kyobe Bosa is the Uganda Ministry of Health Ebola and COVID-19 Incident Commander, and a Senior Research Scientist at Makerere Lung Institute where he is an investigator on a number of studies. He is a co-principal investigator of the TEV Vaccine Trial for Sudan Ebola virus. In Nov 2022, he authored an OpEd in The New York Times titled “Uganda’s Ebola Outbreak Is a Test of What We’ve Learned From Covid” that highlighted the apparent rapture of community confidence in public health interventions as a result of the stringent COVID-19 interventions. Dr Kyobe is a graduate of Makerere University in Uganda, Institute of Tropical Medicine Antwerp in Belgium, University of Ancona in Italy, and University of Washington in the United States. He is also scholar in evidence synthesis (systematic reviews) at University of Oxford, United Kingdom. Henry’s PhD thesis at Makerere University College of Health Sciences focuses on Infectious diseases epidemiology and vaccine immunology, specifically the “Effect of previous exposure to other coronaviruses and adenoviruses on the effectiveness of AstraZeneca SARS CoV-2 Vaccine in Uganda”.
Dr Henry Kyobe Bosa
- Co-Investigator
